Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Enzi Report Finds No Major Concerns With FDA’s Silicone Implant Actions

This article was originally published in The Gray Sheet

Executive Summary

A Senate investigation into FDA's conditional approval of silicone gel-filled breast implants concludes that the agency followed appropriate review procedures

You may also be interested in...



Public Citizen Seeks Criminal Investigation Of Breast-Implant-Maker Mentor

Public Citizen has asked FDA to begin a criminal investigation into allegations that silicone-breast-implant-manufacturer Mentor failed to disclose potential safety problems with its implants, currently under review by the agency

Public Citizen Seeks Criminal Investigation Of Breast-Implant-Maker Mentor

Public Citizen has asked FDA to begin a criminal investigation into allegations that silicone-breast-implant-manufacturer Mentor failed to disclose potential safety problems with its implants, currently under review by the agency

Advisory Panel Reviews Are Too Lenient On Advanced Tech, Report Finds

FDA advisory panels convened to review new devices and pharmaceuticals are not taking their responsibilities seriously enough, the National Research Center for Women & Families charges in an Aug. 28 report

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023846

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel